- Home
- SRDX vs ICG Comparison
SRDX vs ICG Comparison
Compare SRDX & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRDX
- ICG
- Stock Information
- Founded
- SRDX 1979
- ICG 2017
- Country
- SRDX United States
- ICG China
- Employees
- SRDX N/A
- ICG N/A
- Industry
- SRDX Medical/Dental Instruments
- ICG Semiconductors
- Sector
- SRDX Health Care
- ICG Technology
- Exchange
- SRDX Nasdaq
- ICG Nasdaq
- Market Cap
- SRDX 562.6M
- ICG 559.6M
- IPO Year
- SRDX 1998
- ICG 2023
- Fundamental
- Price
- SRDX $36.88
- ICG $4.33
- Analyst Decision
- SRDX Hold
- ICG Strong Buy
- Analyst Count
- SRDX 4
- ICG 1
- Target Price
- SRDX $43.00
- ICG $11.00
- AVG Volume (30 Days)
- SRDX 276.5K
- ICG 587.3K
- Earning Date
- SRDX 01-30-2025
- ICG 02-26-2025
- Dividend Yield
- SRDX N/A
- ICG N/A
- EPS Growth
- SRDX N/A
- ICG N/A
- EPS
- SRDX N/A
- ICG 0.11
- Revenue
- SRDX $126,078,000.00
- ICG $34,648,799.00
- Revenue This Year
- SRDX $13.75
- ICG N/A
- Revenue Next Year
- SRDX $13.67
- ICG $74.94
- P/E Ratio
- SRDX N/A
- ICG $38.92
- Revenue Growth
- SRDX N/A
- ICG 202.16
- 52 Week Low
- SRDX $25.17
- ICG $2.80
- 52 Week High
- SRDX $42.44
- ICG $12.04
- Technical
- Relative Strength Index (RSI)
- SRDX 34.51
- ICG 47.12
- Support Level
- SRDX $34.76
- ICG $3.81
- Resistance Level
- SRDX $37.08
- ICG $4.66
- Average True Range (ATR)
- SRDX 0.90
- ICG 1.64
- MACD
- SRDX -0.33
- ICG -0.11
- Stochastic Oscillator
- SRDX 38.90
- ICG 16.56
About SRDX Surmodics Inc.
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.
About ICG Intchains Group Limited
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments.